Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24782

1.

Chemoprevention agents for melanoma: a path forward into phase 3 clinical trials.

Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB.

Cancer. 2018 Oct 3. doi: 10.1002/cncr.31719. [Epub ahead of print] Review.

PMID:
30281145
2.

A Systematic Review of Evidence-Based Treatments for Prurigo Nodularis.

Qureshi AA, Abate LE, Yosipovitch G, Friedman AJ.

J Am Acad Dermatol. 2018 Sep 24. pii: S0190-9622(18)32628-8. doi: 10.1016/j.jaad.2018.09.020. [Epub ahead of print] Review.

PMID:
30261199
3.

Anticancer Agent-Induced Life-Threatening Skin Toxicities: A Database Study of Spontaneous Reporting Data.

Tanaka R, Yonemori K, Hirakawa A, Kinoshita F, Kobayashi Y, Yamazaki N, Fujimoto M, Tamura K, Fujiwara Y.

Oncologist. 2018 Sep 25. pii: theoncologist.2017-0511. doi: 10.1634/theoncologist.2017-0511. [Epub ahead of print]

PMID:
30254188
4.

A Practical Approach to Chemical Peels: A Review of Fundamentals and Step-by-step Algorithmic Protocol for Treatment.

Soleymani T, Lanoue J, Rahman Z.

J Clin Aesthet Dermatol. 2018 Aug;11(8):21-28. Epub 2018 Aug 1.

5.

Comment on "Excellent response to ustekinumab in a 9-year-old girl with severe psoriasis".

Sanchez-Flores X, Carrasquillo OY, Nevares-Pomales OW, Colon-Fontanez F.

Pediatr Dermatol. 2018 Sep;35(5):701. doi: 10.1111/pde.13589. No abstract available.

PMID:
30211466
6.

Hidradenitis suppurativa/acne inversa: A practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.

Zouboulis CC, Bechara FG, Dickinson-Blok JL, Gulliver W, Horváth B, Hughes R, Kimball AB, Kirby B, Martorell A, Podda M, Prens EP, Ring HC, Tzellos T, van der Zee HH, van Straalen KR, Vossen ARJV, Jemec GBE.

J Eur Acad Dermatol Venereol. 2018 Sep 3. doi: 10.1111/jdv.15233. [Epub ahead of print] Review.

PMID:
30176066
7.

Sarcoidosis secondary to lymphocyte active immunotherapy treated with infliximab.

Souza GH, Thien CI, Castro VB, Gripp AC.

An Bras Dermatol. 2018 Sep-Oct;93(5):764-765. doi: 10.1590/abd1806-4841.20187624. No abstract available.

8.

Testing biologics and intracellular signaling inhibitors on pediatric atopic dermatitis: a stairway to modern therapeutic approaches.

Chiricozzi A, Peroni D, Girolomoni G.

Expert Opin Investig Drugs. 2018 Sep;27(9):699-707. doi: 10.1080/13543784.2018.1516748. Epub 2018 Aug 30. Review.

PMID:
30142984
9.

Pharmacokinetics of tazarotene and acitretin in psoriasis.

Heath MS, Sahni DR, Curry ZA, Feldman SR.

Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):919-927. doi: 10.1080/17425255.2018.1515198. Epub 2018 Sep 3. Review.

PMID:
30134735
10.

Evaluation the effects of oral and topical simvastatin as adjunct therapy in the treatment of acne vulgaris.

Ahmadvand A, Yazdanfar A, Yasrebifar F, Mohammadi Y, Mahjoub R, Mehrpooya M.

Curr Clin Pharmacol. 2018 Aug 21. doi: 10.2174/1574884713666180821143545. [Epub ahead of print]

PMID:
30129417
11.

Novel biological therapeutic approaches to cutaneous lupus erythematosus.

Tayer-Shifman OE, Rosen CF, Wakani L, Touma Z.

Expert Opin Biol Ther. 2018 Oct;18(10):1041-1047. doi: 10.1080/14712598.2018.1513484. Epub 2018 Sep 5.

PMID:
30118337
12.

Anti-oxidative effects of 17 β-estradiol and genistein in human skin fibroblasts and keratinocytes.

Savoia P, Raina G, Camillo L, Farruggio S, Mary D, Veronese F, Graziola F, Zavattaro E, Tiberio R, Grossini E.

J Dermatol Sci. 2018 Oct;92(1):62-77. doi: 10.1016/j.jdermsci.2018.07.007. Epub 2018 Aug 6.

PMID:
30104108
13.

Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.

Stockfleth E, Bastian M.

Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):911-918. doi: 10.1080/17425255.2018.1508449. Epub 2018 Aug 9. Review.

PMID:
30074409
14.

Adult atopic dermatitis: new and emerging therapies.

Napolitano M, Marasca C, Fabbrocini G, Patruno C.

Expert Rev Clin Pharmacol. 2018 Sep;11(9):867-878. doi: 10.1080/17512433.2018.1507734. Epub 2018 Aug 9. Review.

PMID:
30073901
15.

Erythema elevatum diutinum.

Mançano VS, Dinato SLME, Almeida JRP, Romiti N.

An Bras Dermatol. 2018 Jul-Aug;93(4):614-615. doi: 10.1590/abd1806-4841.20187470. No abstract available.

16.

Investigational drugs for atopic dermatitis.

Hon KL, Leung AKC, Leung TNH, Lee VWY.

Expert Opin Investig Drugs. 2018 Aug;27(8):637-647. doi: 10.1080/13543784.2018.1494723. Epub 2018 Jul 30. Review.

PMID:
30058384
17.

Topical rapamycin (sirolimus) for the treatment of uncomplicated tufted angiomas in two children and review of the literature.

Burleigh A, Kanigsberg N, Lam JM.

Pediatr Dermatol. 2018 Sep;35(5):e286-e290. doi: 10.1111/pde.13596. Epub 2018 Jul 17. Review.

PMID:
30015406
18.

Tuberous Sclerosis Complex.

Northrup H, Koenig MK, Pearson DA, Au KS.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
1999 Jul 13 [updated 2018 Jul 12].

19.

What's the story? An analysis of children's books about atopic dermatitis.

Tappel AC, Cresce N, Zlotoff B.

Pediatr Dermatol. 2018 Sep;35(5):607-610. doi: 10.1111/pde.13590. Epub 2018 Jul 9.

PMID:
29984849
20.

Chediak-Higashi Syndrome.

Toro C, Nicoli ER, Malicdan MC, Adams DR, Introne WJ.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2009 Mar 3 [updated 2018 Jul 5].

Supplemental Content

Loading ...
Support Center